Straightforward three-component synthesis of diarylmethylpiperazines and 1,2-diarylethylpiperazines

Tetrahedron

Volumn 63, Issue 18, 2007, Pages 3672-3681

  Sengmany, Stéphane ^a   Le Gall, Erwan ^a   Le Jean, Cédric ^a   Troupel, Michel ^a   Nédélec, Jean Yves ^a  

^a CNRS Université Paris Est Créteil Val de Marne   (France)

Author keywords

1,2 Diarylethylpiperazines; Arylzinc reagents; Benzylzinc reagents; Diarylmethylpiperazines; Three component reaction

Indexed keywords

ALDEHYDE DERIVATIVE; ETHYLPIPERAZINE DERIVATIVE; METHYLPIPERAZINE DERIVATIVE; PARAFORMALDEHYDE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CROSS COUPLING REACTION; PRIORITY JOURNAL; REACTION ANALYSIS; SYNTHESIS;

EID: 33947633056     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.02.086     Document Type: Article

References (43)

1. Opalka C.J., D'Ambra T.E., Faccone J.J., Bodson S., and Cossement E. Synthesis (1995) 766-768
2. Corey E.J., and Helal C.J. Tetrahedron Lett. 37 (1996) 4837-4840
3. Pflum D.A., Wilkinson H.S., Tanoury G.J., Kessler D.W., Kraus H.B., Senanayake C.H., and Wald S.A. Org. Process Res. Dev. 5 (2001) 110-115
4. Several patents describing functional group exchanges of diarylmethylpiperazines in biological screening purpose exist. For some recent examples, see:
5. Brown, W.; Griffin, A.; Penwell, A. World Patent 2006091160, 2006;
6. Chem. Abstr. 145 (2006) 293087
7. Brown, W.; Griffin, A.; Hudzik, T.; Maciag, C.; Smagin, G.; Walpole, C. World Patent 2006014133, 2006;
8. Chem. Abstr. 144 (2006) 212801
9. Brown, W.; Griffin, A. World Patent 2005066148, 2005;
10. Chem. Abstr. 143 (2005) 153402
11. Delorme D., Berthelette C., Lavoie R., and Roberts E. Tetrahedron: Asymmetry 9 (1998) 3963-3966
12. Bishop M.J., and McNutt R.W. Bioorg. Med. Chem. Lett. 5 (1995) 1311-1314
13. Furness M.S., Zhang X., Coop A., Jacobson A.E., Rothman R.B., Dersch C.M., Xu H., Porreca F., and Rice K.C. J. Med. Chem. 43 (2000) 3193-3196
14. The displacement of benzotriazole derivatives using organometallic reagents has been first described by Katritzky. For representative examples, see:
15. Katritzky A.R., Yao G., Lan X., and Zhao X. J. Org. Chem. 58 (1993) 2086-2093
16. Katritzky A.R., Jurczyk S., Rachwal B., Rachwal S., Shcherbakova I., and Yannakopoulou K. Synthesis (1992) 1295-1298
17. Katritzky A.R., Yannakopoulou K., Lue P., Rasala D., and Urogdi L. J. Chem. Soc., Perkin Trans. 1 (1989) 225-233
18. Katritzky A.R., Drewniak M., and Lue P. J. Org. Chem. 53 (1988) 5854-5856
19. Katritzky A.R., Strah S., and Belyakov S.A. Tetrahedron 54 (1998) 7167-7178
20. Plobeck N., Delorme D., Wei Z.Y., Yang H., Zhou F., Schwarz P., Gawell L., Gagnon H., Pelcman B., Schmidt R., Yue S.Y., Walpole C., Brown W., Zhou E., Labarre M., Payza K., St-Onge S., Kamassah A., Morin P.E., Projean D., Ducharme J., and Roberts E. J. Med. Chem. 43 (2000) 3878-3894
21. Barn D.R., Bom A., Cottney J., Caulfield W.L., and Morphy J.R. Bioorg. Med. Chem. Lett. 9 (1999) 1329-1334
22. Calderon S.N., Rice K.C., Rothman R.B., Porreca F., Flippen-Anderson J.L., Kayakiri H., Xu H., Becketts K., Smith L.E., Bilsky E.J., Davis P., and Horvath R. J. Med. Chem. 40 (1997) 695-704
23. Katsura Y., Zhang X., Homma K., Rice K.C., Calderon S.N., Rothman R.B., Yamamura H.I., Davis P., Flippen-Anderson J.L., Xu H., Becketts K., Foltz E.J., and Porreca F. J. Med. Chem. 40 (1997) 2936-2947
24. Zhang X., Rice K.C., Calderon S.N., Kayakiri H., Smith L., Coop A., Jacobson A.E., Rothman R.B., Davis P., Dersch C.M., and Porreca F. J. Med. Chem. 42 (1999) 5455-5463
25. Arend M., Westermann B., and Risch N. Angew. Chem., Int. Ed. 37 (1998) 1044-1070
26. Heaney H. In: Trost B.M., and Fleming I. (Eds). Comprehensive Organic Synthesis Vol. 2 (1991), Pergamon, Oxford 953-973
27. Overman L.E., and Ricca D.J. In: Trost B.M., and Fleming I. (Eds). Comprehensive Organic Synthesis Vol. 2 (1991), Pergamon, Oxford 1007-1046
28. Petasis N.A., and Boral S. Tetrahedron Lett. 42 (2001) 539-542
29. Le Gall E., Troupel M., and Nedelec J.-Y. Tetrahedron Lett. 47 (2006) 2497-2500
30. Le Gall E., Troupel M., and Nedelec J.-Y. Tetrahedron 62 (2006) 9953-9965
31. Fillon H., Gosmini C., and Perichon J. J. Am. Chem. Soc. 125 (2003) 3867-3870
32. 1,2-Diarylethylamines are biologically active compounds. For an example in the treatment of neurotoxic injury, see: Gray, N. M.; Cheng, B. K. European Patent 346791, 1989;
33. Chem. Abstr. 113 (1990) 6165 For more recent examples of their reuptake inhibitor activity, see:
34. Natsuka K., Nishikawa Y., and Nakamura H. Chem. Pharm. Bull. 47 (1999) 1790-1793
35. Fray M.J., Bish G., Brown A.D., Fish P.V., Stobie A., Wakenhut F., and Whitlock G.A. Bioorg. Med. Chem. Lett. 16 (2006) 4345-4348
36. Yuguchi M., Tokuda M., and Orito K. J. Org. Chem. 69 (2004) 908-914
37. Knochel P., and Singer R.D. Chem. Rev. 93 (1993) 2117-2188
38. Knochel P., and Jones P. In: Harwood L.M., and Moody C.J. (Eds). Organozinc Reagents, A Practical Approach (1999), Oxford University Press, Oxford
39. This observation is consistent with Katritzky's work, see Ref. 8e for representative examples of benzylzinc derivatives' handling. It can be noted that dialkylzinc reagents have also been employed in zirconium-catalyzed enantioselective three-component couplings, see:. Porter J.R., Traverse J.F., Hoveyda A.H., and Snapper M.L. J. Am. Chem. Soc. 123 (2001) 10409-10410
40. Cobalt bromide, which is used in catalytic amount during the arylzinc formation is still present in the solution when the aldehyde and the amine are added.
41. Commercial solutions of phenylzinc bromide and 4-methoxyphenylzinc iodide 0.5 M in tetrahydrofuran were supplied by Aldrich.
42. Milne J.E., and Buchwald S.L. J. Am. Chem. Soc. 126 (2004) 13028-13032
43. Ku Y.-Y., Grieme T., Pu Y.-M., Bhatia A.V., and King S.A. Tetrahedron Lett. 46 (2005) 1471-1474